However, the efflux function of ABCG2 causes deleterious effects in cancer cells: it decreases intracellular accumulation of anticancer drugs which leads to lower chemotherapeutic efficacy (Honjo et al., 2001; Polgar et al., 2008, 2; Taylor et al., 2017, 2). This evidence concerns the gene ABCG2 and cancer.